Tracey O’Brien, Chief Cancer Officer and CEO of Cancer Institute NSW, shared a post on LinkedIn:
“One year after BreastScreen NSW led the way as Australia’s first population-based screening program to introduce machine reading technology, it’s now being expanded to include the images of all first-time screeners in NSW.
Supporting radiologists to read mammography images, machine reading technology is ensuring women have the best chance of detecting and treating cancer in its earliest stages through a breast screen.
By the end of this year, it’s predicted that as a direct result of the technology’s accuracy, 20 per cent fewer women will be asked to return for additional tests. That’s around 500 women who no longer have to deal with the stress and anxiety that can come with being told they need to return for further unnecessary tests. This also translates to significant cost saving to the health system and time saving to our in demand specialist radiologists, allowing them to concentrate on more complex tasks.
The BreastScreen NSW team did the groundwork to ensure machine reading technology would benefit women and radiologists. The results so far have exceeded our expectations and I’d like to congratulate the incredible teams involved in introducing this innovative technology.”
More posts featuring Tracey O’Brien on OncoDaily.